Identification of (bio)markers in Dementia with Lewy Bodies.

Identification of (bio)markers in Dementia with Lewy Bodies. - (Bio)markers in Dementia with Lewy Bodies.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44099

Enrollment

230

Registered

2015-08-19

Start date

2015-10-15

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia with Lewy Bodies Lewy body dementia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with (prodromal) Dementia with Lewy Bodies or (prodromal) Parkinson's Disease Dementia (including patients without mild cognitive impairment).

Exclusion criteria

Exclusion criteria: Mini Mental State Examination lower than 20 out of 30 points.

Design outcomes

Primary

Measure	Time frame
The development of a study database and biobank for the identification of new diagnostic and prognostic (bio)markers of Dementia with Lewy Bodies.	—

Secondary

Measure	Time frame
To identify DNA and CSF proteome alterations in familial DLB that could be used as biomarkers of Dementia with Lewy Bodies.	—

Countries

Netherlands

Outcome results